novartis glp-1 receptor agonist Agonists: The New Wave in Diabetes Management GLP-1 Receptor Agonist Market Size,

Poor nutrition and obesity disproportionately affect individuals with lower socioeconomic status in rural communities and in racial and ethnic minoritized populations [226], and disparities in poor nutrition and obesity prevalence are mirrored in disparities in access to quality health care [227]

It mimics GLP-1, a natural gut hormone, to regulate blood sugar, increase insulin, suppress appetite, and promote long-term weight loss

Common Side Effects and Safety Considerations Gastrointestinal side effects are the most frequently reported adverse reactions with GLP-1 receptor agonists, affecting a substantial proportion of patients, particularly during treatment initiation

Diabetes 1995, 44:1126-1131

doi: 10.1177/2042018820935771 22

The glucagon-like peptide 1 analogue restores endothelial dysfunction, induces vasodilatation, and reduces plasma lipids